ATE432700T1 - Indol-4 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren - Google Patents
Indol-4 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatorenInfo
- Publication number
- ATE432700T1 ATE432700T1 AT04763611T AT04763611T ATE432700T1 AT E432700 T1 ATE432700 T1 AT E432700T1 AT 04763611 T AT04763611 T AT 04763611T AT 04763611 T AT04763611 T AT 04763611T AT E432700 T1 ATE432700 T1 AT E432700T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- sulfonamide derivatives
- indol
- modulators
- diastereomers
- Prior art date
Links
- WOYCLZOYKGDAGG-UHFFFAOYSA-N 1h-indole-4-sulfonamide Chemical class NS(=O)(=O)C1=CC=CC2=C1C=CN2 WOYCLZOYKGDAGG-UHFFFAOYSA-N 0.000 title 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- 150000003456 sulfonamides Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301807A ES2222829B1 (es) | 2003-07-30 | 2003-07-30 | Derivados de 4-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos. |
| PCT/EP2004/008512 WO2005013978A1 (en) | 2003-07-30 | 2004-07-29 | Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE432700T1 true ATE432700T1 (de) | 2009-06-15 |
Family
ID=34130541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04763611T ATE432700T1 (de) | 2003-07-30 | 2004-07-29 | Indol-4 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US8097643B2 (de) |
| EP (1) | EP1648446B1 (de) |
| JP (1) | JP2007500166A (de) |
| KR (1) | KR20060123698A (de) |
| CN (1) | CN100518736C (de) |
| AT (1) | ATE432700T1 (de) |
| AU (1) | AU2004262486A1 (de) |
| BR (1) | BRPI0413068A (de) |
| CA (1) | CA2534098A1 (de) |
| DE (1) | DE602004021385D1 (de) |
| EC (2) | ECSP066324A (de) |
| ES (2) | ES2222829B1 (de) |
| IL (1) | IL172892A0 (de) |
| MX (1) | MXPA06001137A (de) |
| NO (1) | NO20060155L (de) |
| NZ (1) | NZ545300A (de) |
| PE (1) | PE20050333A1 (de) |
| PT (1) | PT1648446E (de) |
| RU (1) | RU2006105778A (de) |
| TW (1) | TW200505855A (de) |
| WO (1) | WO2005013978A1 (de) |
| ZA (1) | ZA200600421B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200870385A1 (ru) * | 2006-03-29 | 2009-04-28 | Фолдркс Фармасьютикалз, Инк. | Ингибирование токсичности альфа-синуклеина |
| DE102007007751A1 (de) * | 2007-02-16 | 2008-08-21 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007012284A1 (de) | 2007-03-16 | 2008-09-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| EP2018861A1 (de) * | 2007-07-26 | 2009-01-28 | Laboratorios del Dr. Esteve S.A. | 5HT6-Liganden wie Sulfonamidederivaten bei wirkstoffinduzierter Gewichtszunahme |
| DE102007035334A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| DE102007035333A1 (de) * | 2007-07-27 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel |
| ES2358288T3 (es) | 2007-08-01 | 2011-05-09 | Laboratorios Del Dr. Esteve S.A. | Combinación de al menos dos ligandos de 5ht6. |
| DE102007042154A1 (de) | 2007-09-05 | 2009-03-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel |
| EP2053052A1 (de) | 2007-10-23 | 2009-04-29 | Laboratorios del Dr. Esteve S.A. | Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid |
| ES2562083T3 (es) | 2008-06-06 | 2016-03-02 | Neurmedix, Inc. | Métodos para preparar 17-alquinil-7-hidroxi-esteroides y compuestos relacionados |
| US20190336585A1 (en) * | 2018-05-03 | 2019-11-07 | John Lawrence Mee | Method for sustainable human cognitive enhancement |
| US20190390193A1 (en) * | 2018-06-23 | 2019-12-26 | John Lawrence Mee | Reversible method for sustainable human cognitive enhancement |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3472870A (en) * | 1966-08-29 | 1969-10-14 | Mead Johnson & Co | Sulfonamidotryptamines |
| GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| CZ288897A3 (cs) | 1995-03-20 | 1998-02-18 | Eli Lilly And Company | V poloze 5-substituovaný 3-(1,2,3,6-tetrahydropyridin-4-yl)indol a 3-(piperidin-4-yl)indol a farmaceutický prostředek, který je obsahuje |
| US5939451A (en) * | 1996-06-28 | 1999-08-17 | Hoffmann-La Roche Inc. | Use of sulfonamides |
| GB9902459D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| US6043706A (en) * | 1999-02-05 | 2000-03-28 | Ericsson Inc. | Methods and apparatus for controlling power amplifier quiescent current in a wireless communication device |
| US6521658B1 (en) * | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| WO2002060871A2 (en) * | 2001-01-30 | 2002-08-08 | Eli Lilly And Company | Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
| ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
| ES2313002T3 (es) * | 2003-05-09 | 2009-03-01 | Laboratorios Del Dr. Esteve, S.A. | Uso de derivados de sulfonamida para la fabricacion de un medicamento para la profilaxis y/o tratamiento de la ingestion de alimentos. |
-
2003
- 2003-07-30 ES ES200301807A patent/ES2222829B1/es not_active Expired - Fee Related
-
2004
- 2004-07-29 US US10/566,164 patent/US8097643B2/en not_active Expired - Fee Related
- 2004-07-29 CN CNB2004800221691A patent/CN100518736C/zh not_active Expired - Fee Related
- 2004-07-29 ES ES04763611T patent/ES2327848T3/es active Active
- 2004-07-29 BR BRPI0413068-5A patent/BRPI0413068A/pt not_active Application Discontinuation
- 2004-07-29 RU RU2006105778/04A patent/RU2006105778A/ru unknown
- 2004-07-29 AU AU2004262486A patent/AU2004262486A1/en not_active Abandoned
- 2004-07-29 NZ NZ545300A patent/NZ545300A/en unknown
- 2004-07-29 EP EP04763611A patent/EP1648446B1/de active Active
- 2004-07-29 DE DE602004021385T patent/DE602004021385D1/de active Active
- 2004-07-29 TW TW093122672A patent/TW200505855A/zh unknown
- 2004-07-29 AT AT04763611T patent/ATE432700T1/de not_active IP Right Cessation
- 2004-07-29 CA CA002534098A patent/CA2534098A1/en not_active Abandoned
- 2004-07-29 JP JP2006521530A patent/JP2007500166A/ja active Pending
- 2004-07-29 MX MXPA06001137A patent/MXPA06001137A/es unknown
- 2004-07-29 KR KR1020067001467A patent/KR20060123698A/ko not_active Application Discontinuation
- 2004-07-29 WO PCT/EP2004/008512 patent/WO2005013978A1/en active Application Filing
- 2004-07-29 PT PT04763611T patent/PT1648446E/pt unknown
- 2004-07-29 ZA ZA200600421A patent/ZA200600421B/en unknown
- 2004-08-02 PE PE2004000737A patent/PE20050333A1/es not_active Application Discontinuation
-
2005
- 2005-12-29 IL IL172892A patent/IL172892A0/en unknown
-
2006
- 2006-01-10 NO NO20060155A patent/NO20060155L/no not_active Application Discontinuation
- 2006-01-26 EC EC2006006324A patent/ECSP066324A/es unknown
- 2006-01-26 EC EC2006006322A patent/ECSP066322A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN100518736C (zh) | 2009-07-29 |
| AU2004262486A1 (en) | 2005-02-17 |
| RU2006105778A (ru) | 2007-09-20 |
| EP1648446A1 (de) | 2006-04-26 |
| US20070185158A1 (en) | 2007-08-09 |
| US8097643B2 (en) | 2012-01-17 |
| ES2327848T3 (es) | 2009-11-04 |
| CA2534098A1 (en) | 2005-02-17 |
| MXPA06001137A (es) | 2006-04-24 |
| ECSP066322A (es) | 2006-08-30 |
| IL172892A0 (en) | 2006-06-11 |
| ES2222829B1 (es) | 2006-03-01 |
| PE20050333A1 (es) | 2005-06-12 |
| PT1648446E (pt) | 2009-09-03 |
| KR20060123698A (ko) | 2006-12-04 |
| DE602004021385D1 (de) | 2009-07-16 |
| ES2222829A1 (es) | 2005-02-01 |
| JP2007500166A (ja) | 2007-01-11 |
| TW200505855A (en) | 2005-02-16 |
| WO2005013978A1 (en) | 2005-02-17 |
| EP1648446B1 (de) | 2009-06-03 |
| CN1829508A (zh) | 2006-09-06 |
| NZ545300A (en) | 2008-05-30 |
| ECSP066324A (es) | 2006-08-30 |
| ZA200600421B (en) | 2007-03-28 |
| NO20060155L (no) | 2006-01-10 |
| BRPI0413068A (pt) | 2006-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL172892A0 (en) | Indol-4-sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators | |
| NO20060682L (no) | Indol-6 sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer | |
| GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
| ECSP066325A (es) | Derivados de 5-indolilsulfonamidas, su preparación y su uso como moduladores de 5-ht-6 | |
| ATE327977T1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
| ES2187300A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. | |
| TW200509908A (en) | 1-sulfonylindole derivatives, their preparation and their use in medicaments | |
| ATE335748T1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| SE0302192D0 (sv) | Novel compounds | |
| TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
| DE602006005685D1 (de) | Tetrahydro-beta-karbolin-sulfonamid-derivate als 5-ht6-liganden | |
| EA200801011A1 (ru) | Производные пиразина как модуляторы натриевых каналов для лечения боли | |
| TW200630364A (en) | 2-amido-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
| SG171471A1 (en) | New benzimidazole derivatives | |
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| SE0401970D0 (sv) | Novel compounds | |
| SE0302116D0 (sv) | Novel compounds | |
| SE0403171D0 (sv) | New compounds | |
| WO2005060959A8 (en) | Pyrazole derivatives and use thereof as orexin receptor antagonists | |
| MXPA04001250A (es) | Derivados de arilsulfonilo con afinidad receptora de 5-hidroxitriptamina6 (5-ht6). | |
| SE0300456D0 (sv) | Novel compounds | |
| ECSP066323A (es) | Derivados de 7-indolilsulfonamidas, su preparación y su uso como moduladores de 5-ht-6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1648446 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |